Onkologi

Penanganan Anemia

Obat-obat Penstimulasi Eritropoiesis

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (terbuka di window baru)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Sumber‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Index‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (terbuka di window baru)

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. (terbuka di window baru)

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.

Sumber‎: Acta Haematol 2007;117(3):162-7.

Index‎: PubMed 17148935

DOI‎: 10.1159/000097464

https://www.ncbi.nlm.nih.gov/pubmed/17148935 (terbuka di window baru)

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. (terbuka di window baru)

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

Sumber‎: Am J Hematol 2013;88(12):990-6.

Index‎: PubMed 23873823

DOI‎: 10.1002/ajh.23552

https://www.ncbi.nlm.nih.gov/pubmed/23873823 (terbuka di window baru)

Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. (terbuka di window baru)

Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Würschmidt F, Petry KU, Kimmig R, Elling D, Thomssen C, von Minckwitz G, Möbus V, Hinke A, Kümmel S, Budach V, Lichtenegger W, Schmid P.

Sumber‎: J Clin Oncol 2011;29(28):3791-7.

Index‎: PubMed 21860000

DOI‎: 10.1200/JCO.2010.30.4899

https://www.ncbi.nlm.nih.gov/pubmed/21860000 (terbuka di window baru)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (terbuka di window baru)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Sumber‎: Cancer 2012;118(3):848-55.

Index‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (terbuka di window baru)

Management of anemia in cancer patients. (terbuka di window baru)

Calabrich A, Katz A.

Sumber‎: Future Oncol 2011;7(4):507-17.

Index‎: PubMed 21463140

DOI‎: 10.2217/fon.11.24

https://www.ncbi.nlm.nih.gov/pubmed/21463140 (terbuka di window baru)

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. (terbuka di window baru)

Della Porta MG, Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcárcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Pilot R, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Prebet T, Lai Y, Degulys A, Paolini S, Cluzeau T, Fenaux P, Platzbecker U

Sumber‎: Lancet Haematol 2024;11(9):e646-58.

Index‎: PubMed 39038479

DOI‎: 10.1016/S2352-3026(24)00203-5

https://pubmed.ncbi.nlm.nih.gov/39038479/ (terbuka di window baru)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (terbuka di window baru)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Sumber‎: BJU Int 2011;108(10):1582-7.

Index‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (terbuka di window baru)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (terbuka di window baru)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Sumber‎: J Clin Oncol 2010;28(13):2239-45.

Index‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (terbuka di window baru)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation. (terbuka di window baru)

Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

Sumber‎: Br J Cancer 2011;105(9):1267-72.

Index‎: PubMed 21959870

DOI‎: 10.1038/bjc.2011.395

https://www.ncbi.nlm.nih.gov/pubmed/21959870 (terbuka di window baru)

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome. (terbuka di window baru)

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

Sumber‎: J Intern Med 2017;281(3):284-99.

Index‎: PubMed 27926979

DOI‎: 10.1111/joim.12579

https://www.ncbi.nlm.nih.gov/pubmed/27926979 (terbuka di window baru)

How I treat cancer-associated anemia. (terbuka di window baru)

Gilreath JA, Rodgers GM

Sumber‎: Blood 2020;136(7):801-13.

Index‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (terbuka di window baru)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (terbuka di window baru)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Sumber‎: Eur J Haematol. 2023 110(4):354-61.

Index‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (terbuka di window baru)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (terbuka di window baru)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Sumber‎: Cancer 2013;119(1):107-14.

Index‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (terbuka di window baru)

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. (terbuka di window baru)

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A, Thomssen C, Kurbacher C, Kuhn W, Nitz U, Runnebaum IB, Hinke A, Kreienberg R, Untch M; on behalf of the AGO Breast Study Group.

Sumber‎: J Natl Cancer Inst 2013;105(14):1018-26.

Index‎: PubMed 23860204

DOI‎: 10.1093/jnci/djt145

https://www.ncbi.nlm.nih.gov/pubmed/23860204 (terbuka di window baru)

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. (terbuka di window baru)

Ohashi Y, Uemura Y, Fujisaka Y, Sugiyama T, Ohmatsu H, Katsumata N, Okamoto R, Saijo N, Hotta T.

Sumber‎: Cancer Sci 2013;104(4):481-5.

Index‎: PubMed 23331490

DOI‎: 10.1111/cas.12105

https://www.ncbi.nlm.nih.gov/pubmed/23331490 (terbuka di window baru)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (terbuka di window baru)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Sumber‎: Support Care Cancer 2012;20(1):159-65.

Index‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (terbuka di window baru)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (terbuka di window baru)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Sumber‎: Leuk Lymphoma. 2019;60(9):2324-7.

Index‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (terbuka di window baru)

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial. (terbuka di window baru)

Platzbecker U, Santini V, Fenaux P, Sekeres MA, Savona MR, Madanat YF, Díez-Campelo M, Valcárcel D, Illmer T, Jonášová A, Bělohlávková P, Sherman LJ, Berry T, Dougherty S, Shah S, Xia Q, Sun L, Wan Y, Huang F, Ikin A, Navada S, Feller F, Komrokji RS, Zeidan AM

Sumber‎: Lancet 2024;403(10423):249-60.

Index‎: PubMed 38048786

DOI‎: 10.1016/S0140-6736(23)01724-5

https://pubmed.ncbi.nlm.nih.gov/38048786/ (terbuka di window baru)

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. (terbuka di window baru)

Pronzato P, Cortesi E, van der Rijt CC, Bols A, Moreno-Nogueira JA, de Oliveira CF, Barrett-Lee P, Ostler PJ, Rosso R; for the EPO-INT-47 Study Group.

Sumber‎: Oncologist 2010;15(9):935-43.

Index‎: PubMed 20798194

DOI‎: 10.1634/theoncologist.2009-0279

https://www.ncbi.nlm.nih.gov/pubmed/20798194 (terbuka di window baru)

The effect of erythropoiesis-stimulating agents on lung cancer patients: a meta-analysis. (terbuka di window baru)

Tong Z, Xu Z, Duan Y, Sun X, Qi B

Sumber‎: Clin Exp Med 2024;24(1):150.

Index‎: PubMed 38967734

DOI‎: 10.1007/s10238-024-01391-3

https://pubmed.ncbi.nlm.nih.gov/38967734/ (terbuka di window baru)

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. (terbuka di window baru)

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Sumber‎: Lung Cancer 2012;76(3):478-85.

Index‎: PubMed 22277104

DOI‎: 10.1016/j.lungcan.2011.12.015

https://www.ncbi.nlm.nih.gov/pubmed/22277104 (terbuka di window baru)

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia. (terbuka di window baru)

Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G.

Sumber‎: Eur J Haematol 2016;97(1):33-8.

Index‎: PubMed 26341961

DOI‎: 10.1111/ejh.12679

https://www.ncbi.nlm.nih.gov/pubmed/26341961 (terbuka di window baru)

Besi Intravena

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (terbuka di window baru)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Sumber‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Index‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (terbuka di window baru)

Intravenous iron in oncology. (terbuka di window baru)

Auerbach M, Ballard H.

Sumber‎: J Natl Compr Canc Netw 2008;6(6):585-92.

Index‎: PubMed 18597712

https://www.ncbi.nlm.nih.gov/pubmed/18597712 (terbuka di window baru)

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. (terbuka di window baru)

Calleja JL, Delgado S, Del Val A, Hervás A, Larraona JL, Terán Á, Cucala M, Mearin F; Colon Cancer Study Group.

Sumber‎: Int J Colorectal Dis 2016;31(3):543-51.

Index‎: PubMed 26694926

DOI‎: 10.1007/s00384-015-2461-x

https://www.ncbi.nlm.nih.gov/pubmed/26694926 (terbuka di window baru)

How I treat cancer-associated anemia. (terbuka di window baru)

Gilreath JA, Rodgers GM

Sumber‎: Blood 2020;136(7):801-13.

Index‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (terbuka di window baru)

Total dose iron dextran infusion in cancer patients: is it SaFe2+? (terbuka di window baru)

Gilreath JA, Stenehjem DD, Rodgers GM.

Sumber‎: J Natl Compr Canc Netw 2012;10(5):669-76.

Index‎: PubMed 22570295

https://www.ncbi.nlm.nih.gov/pubmed/22570295 (terbuka di window baru)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (terbuka di window baru)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Sumber‎: Eur J Haematol. 2023 110(4):354-61.

Index‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (terbuka di window baru)

Intravenous iron therapy to treat anemia in oncology: a mapping review of randomized controlled trials. (terbuka di window baru)

Lim J, Auerbach M, MacLean B, Al-Sharea A, Richards T

Sumber‎: Curr Oncol. 2023 24;30(9):7836-51.

Index‎: PubMed 37754484

DOI‎: 10.3390/curroncol30090569

https://pubmed.ncbi.nlm.nih.gov/37754484/ (terbuka di window baru)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (terbuka di window baru)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Sumber‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Index‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (terbuka di window baru)

Perioperative anemia management in colorectal cancer patients: a pragmatic approach. (terbuka di window baru)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M.

Sumber‎: World J Gastroenterol 2014;20(8):1972-85.

Index‎: PubMed 24587673

DOI‎: 10.3748/wjg.v20.i8.1972

https://www.ncbi.nlm.nih.gov/pubmed/24587673 (terbuka di window baru)

Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries. (terbuka di window baru)

Parikh PM, Aggarwal S, Biswas G, Gulia S, Agarwala V, Basade M, Mohapatra PN, Vamshi KM, Warrier A, Prasad K, Roy P, Chandrakant MV, Malhotra H, Hingmire S, Paul D, Maniar V, Gupta A, Panda SS, Samar A, Rohatgi N, Dattatreya S, Krishnamurthy M, Thirumalairaj R

Sumber‎: South Asian J Cancer. 2023 15;12(2):93-9.

Index‎: PubMed 37969669

DOI‎: 10.1055/s-0043-1771445

https://pubmed.ncbi.nlm.nih.gov/37969669/ (terbuka di window baru)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (terbuka di window baru)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Sumber‎: J Clin Oncol 2008;26(10):1619-25.

Index‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (terbuka di window baru)

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. (terbuka di window baru)

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

Sumber‎: J Cancer Res Clin Oncol 2012;138(2):179-87.

Index‎: PubMed 21972052

DOI‎: 10.1007/s00432-011-1072-3

https://www.ncbi.nlm.nih.gov/pubmed/21972052 (terbuka di window baru)

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. (terbuka di window baru)

Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.

Sumber‎: Ann Oncol 2013;24(2):475-82.

Index‎: PubMed 23071262

DOI‎: 10.1093/annonc/mds338

https://www.ncbi.nlm.nih.gov/pubmed/23071262 (terbuka di window baru)

Expert consensus guidelines: intravenous iron uses, formulations, administration, and management of reactions. (terbuka di window baru)

Van Doren L, Steinheiser M, Boykin K, Taylor KJ, Menendez M, Auerbach M

Sumber‎: Am J Hematol 2024;99(7):1338-48.

Index‎: PubMed 38282557

DOI‎: 10.1002/ajh.27220

https://pubmed.ncbi.nlm.nih.gov/38282557/ (terbuka di window baru)

ONKOLOGI
Penanganan Anemia
Indonesia
Penanganan Anemia
/assets/ct/f2de21bac4/images/syn_placeholder_sqr.png

Hubungi Perwakilan Setempat dari Panitia Penghubung Rumah Sakit

Layanan gratis sedunia, tersedia 24 jam setiap hari bagi para dokter yang menangani Saksi-Saksi Yehuwa.

Kontak

Paket Informasi Medis

Topiknya antara lain: Strategi klinis untuk menangani perdarahan dan anemia tanpa transfusi darah, etika dan pendirian Saksi-Saksi Yehuwa tentang perawatan medis, dan pelayanan yang diberikan Saksi Yehuwa kepada dunia medis melalui jaringan Panitia Penghubung Rumah Sakit di seluruh dunia.

Download

Video

Video: Pilihan perawatan maupun pertimbangan dalam hal kesehatan dan etika bagi dokter yang merawat Saksi-Saksi Yehuwa.

Lihat Video